Drug Shortage Report for LUPRON DEPOT

Last updated on 2020-10-15 History
Report ID 126544
Drug Identification Number 00884502
Brand name LUPRON DEPOT
Common or Proper name Lupron depot 3.75mg
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) LEUPROLIDE ACETATE
Strength(s) 3.75MG
Dosage form(s) POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 syringe (3.75mg)
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-10-14
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-10-15
Company comments Please rest assured that we still have inventory of LUPRON Depot 3.75mg (1-month SR). However, due to a recent surge in demand, orders of LUPRON Depot 3.75mg (1-month SR) may take longer to fulfill. We are working closely with wholesalers to fulfill orders in a judicious manner to ensure a constant supply of medication to support patients during this period. Important note: Only LUPRON Depot 3.75 mg (1-Month SR) and LUPRON Depot 11.25 mg (3-Month SR) formulations have gynecologic indications. Other formulations of LUPRON Depot are not indicated in gynecology.
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-10-15 French Compare
v1 2020-10-15 English Compare